Showing results (881-890 of 1,024) with videos related to

Sort By:
Pageof 103
Antimicrobial Agents and Chemotherapy|December 11, 2019
Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon MutagenesisMichael S Sonnabend, Kristina Klein, Sina Beier, et al.
Plos One|November 3, 2018
Associations of birth mode with cord blood cytokines, white blood cells, and newborn intestinal bifidobacteriaIsabel Cristina Ribas Werlang, Noel Theodore Mueller, Aline Pizoni, et al.
British Journal of Clinical Pharmacology|January 24, 2019
Population pharmacokinetics of lenalidomide in patients with B-cell malignanciesJim H Hughes, Mitch A Phelps, Richard N Upton, et al.
Harmful Algae|November 24, 2021
Acute oral toxicity and tissue residues of saxitoxin in the mallard (Anas platyrhynchos)Robert J Dusek, Matthew M Smith, Caroline Van Hemert, et al.
Medicine|July 26, 2024
A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementiasJonathan Haroon, Kaya Jordan, Kennedy Mahdavi, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2025
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 InstitutesCindy Varga, Myra Robinson, Vikas Gupta, et al.
Cancer Immunology, Immunotherapy : CII|May 9, 2012
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanomaJürgen C Becker, Mads H Andersen, Valeska Hofmeister-Müller, et al.
Journal of Geriatric Oncology|July 10, 2018
Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplantAshley E Rosko, Ying Huang, Don M Benson, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 22, 2018
Pharmacokinetic-Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell TransplantYu Kyoung Cho, Donald J Irby, Junan Li, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2013
Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCCShauna M Collins, Courtney E Bakan, Gina D Swartzel, et al.
Pageof 103